JP2012527218A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012527218A5 JP2012527218A5 JP2012511093A JP2012511093A JP2012527218A5 JP 2012527218 A5 JP2012527218 A5 JP 2012527218A5 JP 2012511093 A JP2012511093 A JP 2012511093A JP 2012511093 A JP2012511093 A JP 2012511093A JP 2012527218 A5 JP2012527218 A5 JP 2012527218A5
- Authority
- JP
- Japan
- Prior art keywords
- mycoplasma hyopneumoniae
- vaccine
- strain
- disease caused
- vaccine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 14
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims 13
- 238000000034 method Methods 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 241000282898 Sus scrofa Species 0.000 claims 4
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 claims 3
- 206010035664 Pneumonia Diseases 0.000 claims 3
- 206010035724 Pneumonia mycoplasmal Diseases 0.000 claims 3
- 239000012678 infectious agent Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 241000204003 Mycoplasmatales Species 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000002703 mutagenesis Methods 0.000 claims 1
- 231100000350 mutagenesis Toxicity 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2009902255A AU2009902255A0 (en) | 2009-05-19 | Bacterial strain, vaccine and uses thereof | |
| AU2009902255 | 2009-05-19 | ||
| PCT/AU2010/000590 WO2010132932A1 (en) | 2009-05-19 | 2010-05-19 | A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012527218A JP2012527218A (ja) | 2012-11-08 |
| JP2012527218A5 true JP2012527218A5 (https=) | 2013-06-20 |
| JP5744852B2 JP5744852B2 (ja) | 2015-07-08 |
Family
ID=43125658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511093A Active JP5744852B2 (ja) | 2009-05-19 | 2010-05-19 | Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅの温度感受性ワクチン株およびその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8524252B2 (https=) |
| EP (1) | EP2453913B1 (https=) |
| JP (1) | JP5744852B2 (https=) |
| KR (1) | KR101734590B1 (https=) |
| CN (1) | CN102458462B (https=) |
| AU (1) | AU2010251761B2 (https=) |
| BR (1) | BRPI1010679B1 (https=) |
| CA (1) | CA2762587C (https=) |
| CL (1) | CL2011002923A1 (https=) |
| DK (1) | DK2453913T3 (https=) |
| EA (1) | EA021102B1 (https=) |
| ES (1) | ES2579935T3 (https=) |
| MX (1) | MX2011012362A (https=) |
| NZ (1) | NZ596722A (https=) |
| PE (1) | PE20120909A1 (https=) |
| WO (1) | WO2010132932A1 (https=) |
| ZA (1) | ZA201109185B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2571980A4 (en) | 2010-05-19 | 2014-02-26 | Bioproperties Pty Ltd | METHOD RELATED TO A WEAKEN MYCOPLASMA |
| CN104685057B (zh) * | 2012-07-10 | 2019-04-16 | 海博莱科学有限公司 | 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途 |
| EP2684959A1 (en) * | 2012-07-10 | 2014-01-15 | Laboratorios Hipra, S.A. | Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof |
| PT2938747T (pt) | 2012-12-28 | 2019-08-01 | Boehringer Ingelheim Vetmedica Gmbh | Método de preparação de uma vacina de micoplasma |
| SG11201505086QA (en) | 2012-12-28 | 2015-07-30 | Boehringer Ingelheim Vetmed | Immunogenic composition comprising mycoplasma antigens |
| EP2913947B1 (en) * | 2014-02-27 | 2019-11-27 | ADVA Optical Networking SE | Passive optical network and optical line terminal |
| KR20160099223A (ko) * | 2015-02-12 | 2016-08-22 | 강원대학교산학협력단 | 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법 |
| US10071149B2 (en) | 2016-05-03 | 2018-09-11 | Brigham Young University | Temperature sensitive multivalent Bordetella avium vaccines |
| CN113278575B (zh) * | 2021-07-13 | 2021-12-31 | 南华大学 | 一种肺炎支原体减毒突变株及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN178995A0 (en) * | 1995-03-16 | 1995-04-13 | University Of Melbourne, The | Antigen composition |
| CN1100871C (zh) * | 1999-06-25 | 2003-02-05 | 江苏省农业科学院畜牧兽医研究所 | 猪肺炎支原体克隆致弱株 |
| US6673567B2 (en) * | 2000-03-23 | 2004-01-06 | E. I. Du Pont De Nemours And Company | Method of determination of gene function |
| US6585981B1 (en) | 2000-07-27 | 2003-07-01 | Regents Of The University Of Minnesota | Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
| MY129765A (en) * | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
| WO2003004051A2 (en) * | 2001-07-02 | 2003-01-16 | Pfizer Products Inc. | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| US7691368B2 (en) * | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| EP1991262A4 (en) * | 2006-03-03 | 2009-11-04 | Merial Ltd | MYCOPLASMA HYOPNEUMONIAE VACCINE |
| UA98812C2 (ru) * | 2007-11-06 | 2012-06-25 | Вайет Ллк | Авирулентная активированная живая вакцина mycoplasma hyopneumoniae |
| UA107940C2 (en) * | 2009-09-10 | 2015-03-10 | Merial Ltd | The vaccine composition that includes the saponin-containing adjuvant |
| US9324223B2 (en) | 2012-06-08 | 2016-04-26 | 3M Innovative Properties Company | Electronic monitoring home unit and installation methods |
-
2010
- 2010-05-19 WO PCT/AU2010/000590 patent/WO2010132932A1/en not_active Ceased
- 2010-05-19 EA EA201190311A patent/EA021102B1/ru not_active IP Right Cessation
- 2010-05-19 CA CA2762587A patent/CA2762587C/en active Active
- 2010-05-19 ES ES10777221.2T patent/ES2579935T3/es active Active
- 2010-05-19 EP EP10777221.2A patent/EP2453913B1/en active Active
- 2010-05-19 KR KR1020117030155A patent/KR101734590B1/ko active Active
- 2010-05-19 US US13/321,662 patent/US8524252B2/en active Active
- 2010-05-19 JP JP2012511093A patent/JP5744852B2/ja active Active
- 2010-05-19 MX MX2011012362A patent/MX2011012362A/es active IP Right Grant
- 2010-05-19 BR BRPI1010679-0A patent/BRPI1010679B1/pt active IP Right Grant
- 2010-05-19 NZ NZ596722A patent/NZ596722A/xx unknown
- 2010-05-19 DK DK10777221.2T patent/DK2453913T3/en active
- 2010-05-19 CN CN201080031403.2A patent/CN102458462B/zh active Active
- 2010-05-19 PE PE2011001988A patent/PE20120909A1/es not_active Application Discontinuation
- 2010-05-19 AU AU2010251761A patent/AU2010251761B2/en active Active
-
2011
- 2011-11-18 CL CL2011002923A patent/CL2011002923A1/es unknown
- 2011-12-13 ZA ZA2011/09185A patent/ZA201109185B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012527218A5 (https=) | ||
| Maroof et al. | Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection | |
| JP2015536134A5 (https=) | ||
| Lee et al. | Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection | |
| HRP20141258T1 (hr) | 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat | |
| JP2013519645A5 (https=) | ||
| RU2013119946A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| Gong et al. | Construction of a ptfA chitosan nanoparticle DNA vaccine against Pasteurella multocida and the immune response in chickens | |
| HRP20150177T1 (hr) | Cjepivo protiv tuberkuloze i postupak upotrebe tog cjepiva | |
| JP2012001565A5 (https=) | ||
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| Gong et al. | Evaluation of protective efficacy of inactivated Mycoplasma synoviae vaccine with different adjuvants | |
| Lacámara et al. | MTBVAC: a tuberculosis vaccine candidate advancing towards clinical efficacy trials in TB prevention | |
| Deng et al. | Adjuvant effects of interleukin-2 co-expression with VP60 in an oral vaccine delivered by attenuated Salmonella typhimurium against rabbit hemorrhagic disease | |
| Zhao et al. | Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo | |
| JP2013515490A5 (https=) | ||
| AU2013351213B2 (en) | Vaccine to protect a ruminant against pneumonia caused by Pasteurella multocida | |
| Hajam et al. | Preexisting Salmonella-specific immunity interferes with the subsequent development of immune responses against the Salmonella strains delivering H9N2 hemagglutinin | |
| JP2017501985A (ja) | ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン | |
| MX2019006831A (es) | Vacuna oral contra enfermedades respiratorias de ruminantes que contiene polivinilpirrolidona. | |
| JP2013526504A (ja) | 母系由来の抗体の存在下での投与に適したマイコプラズマ・ハイオニュ−モニエに対するワクチン | |
| Yi et al. | Age-dependent cytokine expression in response to foot-and-mouth disease virus in bovine peripheral blood mononuclear cells. | |
| Oma et al. | Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice | |
| Zhang et al. | aroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge | |
| Markowska-Daniel et al. | Emergence of the pandemic H1N1 2009 influenza A virus in swine herds in Poland |